These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1813019)

  • 1. Structural heterogeneity and functional differentiation: a rationale for glycosylation analysis of recombinant therapeutics.
    Cumming DA
    Semin Cell Biol; 1991 Oct; 2(5):273-9. PubMed ID: 1813019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological relevance of protein glycosylation.
    Cumming DA
    Dev Biol Stand; 1992; 76():83-94. PubMed ID: 1478359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled glycosylation of therapeutic antibodies in plants.
    Tekoah Y; Ko K; Koprowski H; Harvey DJ; Wormald MR; Dwek RA; Rudd PM
    Arch Biochem Biophys; 2004 Jun; 426(2):266-78. PubMed ID: 15158677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of the extracellular domain of the membrane protein GlialCAM expressed in HEK and CHO cells and comparison of the glycosylation.
    Gaudry JP; Arod C; Sauvage C; Busso S; Dupraz P; Pankiewicz R; Antonsson B
    Protein Expr Purif; 2008 Mar; 58(1):94-102. PubMed ID: 18082421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals.
    Srebalus Barnes CA; Lim A
    Mass Spectrom Rev; 2007; 26(3):370-88. PubMed ID: 17410555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression--glycosylation.
    Parekh RB
    Biologicals; 1994 Jun; 22(2):113-9. PubMed ID: 7917227
    [No Abstract]   [Full Text] [Related]  

  • 7. Peptide, disulfide, and glycosylation mapping of recombinant human thrombopoietin from ser1 to Arg246.
    Hoffman RC; Andersen H; Walker K; Krakover JD; Patel S; Stamm MR; Osborn SG
    Biochemistry; 1996 Nov; 35(47):14849-61. PubMed ID: 8942648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent heterogeneity of recombinant interferon gamma receptors produced in prokaryotic and eukaryotic expression systems.
    Fountoulakis M
    J Chem Technol Biotechnol; 1996 Feb; 65(2):123-30. PubMed ID: 8672294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-translational modifications in the context of therapeutic proteins.
    Walsh G; Jefferis R
    Nat Biotechnol; 2006 Oct; 24(10):1241-52. PubMed ID: 17033665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of the molecular heterogeneity of gut hormones.
    Rehfeld JF; Andersen BN; Petersen B
    Scand J Gastroenterol Suppl; 1983; 82():19-24. PubMed ID: 6579626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranslational modification of the glycosylation inhibiting factor (GIF) gene product generates bioactive GIF.
    Watarai H; Nozawa R; Tokunaga A; Yuyama N; Tomas M; Hinohara A; Ishizaka K; Ishii Y
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13251-6. PubMed ID: 11069294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of N-glycans of recombinant human thyrotropin using mass spectrometry.
    Morelle W; Donadio S; Ronin C; Michalski JC
    Rapid Commun Mass Spectrom; 2006; 20(3):331-45. PubMed ID: 16372382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence against posttranslational glycosylation of rat glucocorticoid receptors.
    Yen PM; Simons SS
    Receptor; 1991; 1(3):191-205. PubMed ID: 1843207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baculovirus-mediated expression and purification of human FMO3: catalytic, immunochemical, and structural characterization.
    Haining RL; Hunter AP; Sadeque AJ; Philpot RM; Rettie AE
    Drug Metab Dispos; 1997 Jul; 25(7):790-7. PubMed ID: 9224773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The two N-glycans present on bovine Pofut1 are differently involved in its solubility and activity.
    Loriol C; Audfray A; Dupuy F; Germot A; Maftah A
    FEBS J; 2007 Mar; 274(5):1202-11. PubMed ID: 17263732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemistry. Mimicking posttranslational modifications of proteins.
    Davis BG
    Science; 2004 Jan; 303(5657):480-2. PubMed ID: 14739446
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression, purification, and characterization of the recombinant proform of eosinophil granule major basic protein.
    Popken-Harris P; McGrogan M; Loegering DA; Checkel JL; Kubo H; Thomas LL; Moy JN; Sottrup-Jensen L; Snable JL; Kikuchi MT
    J Immunol; 1995 Aug; 155(3):1472-80. PubMed ID: 7543523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone variants and histone modifications: a structural perspective.
    Ausió J; Abbott DW; Wang X; Moore SC
    Biochem Cell Biol; 2001; 79(6):693-708. PubMed ID: 11800010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, characterization, and biochemical properties of recombinant human salivary amylase.
    Ragunath C; Sundar K; Ramasubbu N
    Protein Expr Purif; 2002 Mar; 24(2):202-11. PubMed ID: 11858714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The active site of human glucocerebrosidase: structural predictions and experimental validations].
    Fabrega S; Durand P; Mornon JP; Lehn P
    J Soc Biol; 2002; 196(2):151-60. PubMed ID: 12360744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.